Newsroom
-
Bayer jumps on board Mammoth’s ultra-small CRISPR tech with sights set first on liver disease
Endpoints NewsLearn More -
Bayer to pay CRISPR-focused Mammoth Biosciences $40 million for gene editing research
STAT NewsLearn More -
Bayer and Mammoth Biosciences to collaborate on novel gene editing technology
Business WireLearn More -
Mammoth Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference
Business WireLearn More -
Mammoth Biosciences Inks 691 Million Deal to Develop Crispr Gene Editing Therapies
ForbesLearn More -
Vertex signs another Mammoth-sized CRISPR deal with $650M in biobucks on the line
Fierce BiotechLearn More -
UPDATED: Jennifer Doudna spinout inks a Mammoth CRISPR deal with Vertex worth nearly $700M
Endpoints NewsLearn More -